Epidemiology Thyroid Cancer

Rodrigo Arrangoiz MS, MD, FACS, FSSO

img_3421

 

Presentation1

  • Estimated new cases of thyroid cancer in 2019:52, 070 cases3% of all new cancer cases reported in the United States
  • Estimated deaths from thyroid cancer in 2019:2,170 deaths0.4% of all cancer deaths in the United States 
  • Number of New Cases and Deaths per 100,000 individual:The number of new cases of thyroid cancer:Was 15.8 per 100,000 men and women per yearThe number of deaths:Was 0.5 per 100,000 men and women per year:These rates are age-adjusted and based on 2012 to 2016 cases and deaths.
  • Lifetime Risk of Developing Thyroid Cancer: Approximately 1.3% of men and women will be diagnosed with thyroid cancer at some point during their lifetime:Based on 2014 to 2016 data.
  • Prevalence of Thyroid Cancer: In 2016:There were an estimated 822,242 people living with thyroid cancer in the United States.

Presentation1

  • How Many People Survive Five-Years Or More after Being Diagnosed with Thyroid Cancer?98.2% of patients diagnosed with thyroid cancer will be alive at 5-years:Relative survival statistics:Compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and gender and who have not been diagnosed with cancer.
        • Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient:No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

Presentation1

  • Survival by Stage:
    • Cancer stage at diagnosis:
      • Which refers to extent of a cancer in the body:Determines treatment options and has a strong influence on the length of survival.
        • In general, if the cancer is found only in the part of the body where it started it is:
          • Localized (sometimes referred to as stage 1).
        • If it has spread to a different part of the body:
          • The stage is regional or distant.
      • The earlier thyroid cancer is caught:
        • The better chance a person has of surviving five years after being diagnosed:
          • For thyroid cancer:
            • 67.0% are diagnosed at the local stage:The 5-year survival for localized thyroid cancer is:
                • 99.9%
            • 27% are diagnosed with regional lymph node metastasis:
              • The 5-year survival for thyroid cancer with regional metastasis is:
                • 98.2%
            • 4% are diagnosed with distant metastasis:
              • The 5-year survival for metastatic thyroid cancer is:
                • 58.2%

Presentation1

prof_739_20190417135234

  • Rodrigo Arrangoiz MS, MD, FACS miembro de Sociedad Quirúrgica S.C. es experto en el manejo de la patología de la glándula tiroides:
    • El Dr. Arrangoiz tiene entrenamiento en:Cirugía de tumores de cabeza y cuello, cirugía endocrina, y cirugía oncológica.
  • Es pionero en México de la:
    • Cirugia tiroidea minimamente invasiva
    • La cirugia minimamente invasiva radio-guiada de paratiroides
  •  Su entrenamiento es el siguiente:
    • Tumores de Cabeza y Cuello / Cirugía Endocrina – Fox Chase Cancer Center

image-49

  • Tumores de Cabeza y Cuello / Cirugía Endocrina – IFHNOS / Memorial Sloan Kettering Cancer Center
image-46
image-47
  • Cirugía Oncológica Compleja – Fox Chase Cancer Center

image-39

 

  • Cirugia General y Gastrointestinal:
    • Michigan State University

images

  • Maestría en Ciencias de InvestigaciónDrexel University

image-40

  • El Dr. Arrangoiz esta certificado por:
    • El Colegio Americano de Cirugía

Unknown

 

  • Es fellow de la Sociedad de Cirugia Oncológica:

Unknown

  • Miembro de la American Thyroid Association:

Unknown

Sociedad Quirúrgica S.C.
Hospital ABC Santa Fé
Av. Carlos Graef Fernández #154
Consultorio 515
Col. Tlaxala, Delg. Cuajimalpa
México, D.F. 05300
Tel: 1103 – 1600 Ext 4515 a la 4517
Fax:1664 – 7164
rodrigo.arrangoiz@gmail.com
Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment